Spinogenix
Clinical trials sponsored by Spinogenix, explained in plain language.
-
New drug trial aims to boost brain function in genetic disorder
Disease control Not yet recruitingThis study is testing whether an investigational drug called SPG601 can improve thinking skills, behavior, and daily functioning in adult men with Fragile X syndrome. The trial will enroll 248 participants who will receive either the drug or a placebo for several weeks. Researche…
Phase: PHASE2, PHASE3 • Sponsor: Spinogenix • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
New drug trial aims to slow devastating ALS progression
Disease control Not yet recruitingThis study is testing whether an oral drug called tazbentetol can slow the progression of ALS and improve patients' daily function and quality of life. It will involve about 430 adults with ALS, who will receive either the drug or a placebo for 36 weeks. The main goal is to see i…
Phase: PHASE2, PHASE3 • Sponsor: Spinogenix • Aim: Disease control
Last updated Mar 17, 2026 13:09 UTC